No one is looking at what happened to Roche itself. Roche which owns in the mid 50% of Genentech and is a powerhouse all by itself only has a marketcap in the area of $110 Billion dollars.
Roche has lost a lot of marketcap itself, so I would think DNA holders would be lucky to take the current offer.